Linklaters advises Carlyle Global Credit on its strategic investment in Orifarm

Linklaters has advised global investment firm Carlyle Global Credit on its strategic capital investment in Orifarm Group A/S, a family-owned, international healthcare company which supplies high quality pharmaceuticals at affordable prices across three business lines: Pharma Trade, Specialty Rx and Consumer Healthcare.

Andrew Lynch comments:

“We were delighted to support our longstanding client, Carlyle, on its strategic investment in Orifarm, which is a terrific example of our capital solutions and leveraged finance capabilities. We continue to see strong demand from companies for flexible financing solutions and financial sponsors are well placed to support these requirements. We are supporting a significant number of our financial sponsors clients in delivering innovative and bespoke structures which meet the specific needs, sensitivities and objectives of the companies into which they invest.“

The Linklaters team was led by Private Equity and Special Situations partner Andrew Lynch alongside Leveraged Finance partner Pathik Gandhi. They were supported by Leveraged Finance counsel Jo Jimenez, Private Equity associates Nitesh Nagrath and Kavi Shah, and Leveraged Finance associate Millie Bidwill. Antitrust and Foreign Investment partners Neil Hoolihan and Ina Lunneryd led on competition aspects of the transaction, and partner Jana Hager advised on Healthcare aspects.